N-hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8

Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, et al. (2006)
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 16(1): 20-24.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ; ;
All
Abstract
The first crystallographic structure of an N-hydroxyurea inhibitor bound into the active site of a matrix metalloproteinase is reported. The ligand and three other analogues were prepared and studied as inhibitors of MMP-2, MMP-3, and MMP-8. The crystal structure of the complex with MMP-8 shows that the N-hydroxyurea, contrary to the analogous hydroxamate, binds the catalytic zinc ion in a monodentate rather than bidentate mode and with high out-of-plane distortion of the amide bonds. (c) 2005 Elsevier Ltd. All rights reserved.
Publishing Year
ISSN
PUB-ID

Cite this

Campestre C, Agamennone M, Tortorella P, et al. N-hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2006;16(1):20-24.
Campestre, C., Agamennone, M., Tortorella, P., Preziuso, S., Biasone, A., Gavuzzo, E., Pochetti, G., et al. (2006). N-hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 16(1), 20-24.
Campestre, C., Agamennone, M., Tortorella, P., Preziuso, S., Biasone, A., Gavuzzo, E., Pochetti, G., Mazza, F., Hiller, O., Tschesche, H., et al. (2006). N-hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 16, 20-24.
Campestre, C., et al., 2006. N-hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 16(1), p 20-24.
C. Campestre, et al., “N-hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8”, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 16, 2006, pp. 20-24.
Campestre, C., Agamennone, M., Tortorella, P., Preziuso, S., Biasone, A., Gavuzzo, E., Pochetti, G., Mazza, F., Hiller, O., Tschesche, H., Consalvi, V., Gallina, C.: N-hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 16, 20-24 (2006).
Campestre, C, Agamennone, M, Tortorella, P, Preziuso, S, Biasone, A, Gavuzzo, E, Pochetti, G, Mazza, F, Hiller, O, Tschesche, Harald, Consalvi, V, and Gallina, C. “N-hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8”. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 16.1 (2006): 20-24.
This data publication is cited in the following publications:
This publication cites the following data publications:

18 Citations in Europe PMC

Data provided by Europe PubMed Central.

Ribonucleotide reductase metallocofactor: assembly, maintenance and inhibition.
Zhang C, Liu G, Huang M., Front Biol (Beijing) 9(2), 2014
PMID: 24899886
Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.
Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P., Bioorg. Med. Chem. Lett. 24(12), 2014
PMID: 24813742
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P., Bioorg. Med. Chem. 21(21), 2013
PMID: 24071448
Synthesis and evaluation of inhibitors of E. coli PgaB, a polysaccharide de-N-acetylase involved in biofilm formation.
Chibba A, Poloczek J, Little DJ, Howell PL, Nitz M., Org. Biomol. Chem. 10(35), 2012
PMID: 22855025
Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas.
Palermo G, Branduardi D, Masetti M, Lodola A, Mor M, Piomelli D, Cavalli A, De Vivo M., J. Med. Chem. 54(19), 2011
PMID: 21830831
Biphenyl sulfonylamino methyl bisphosphonic acids as inhibitors of matrix metalloproteinases and bone resorption.
Rubino MT, Agamennone M, Campestre C, Campiglia P, Cremasco V, Faccio R, Laghezza A, Loiodice F, Maggi D, Panza E, Rossello A, Tortorella P., ChemMedChem 6(7), 2011
PMID: 21714093
Identification of novel matrix metalloproteinase inhibitors by screening of phenol fragments library.
Rubino MT, Maggi D, Laghezza A, Loiodice F, Tortorella P., Arch. Pharm. (Weinheim) 344(9), 2011
PMID: 21695711
Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.
Durrant JD, de Oliveira CA, McCammon JA., Chem Biol Drug Des 78(2), 2011
PMID: 21609408
Keloids: a new challenge for nutrition.
Ferreira AC, Hochman B, Furtado F, Bonatti S, Ferreira LM., Nutr. Rev. 68(7), 2010
PMID: 20591108
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.
Durrant JD, de Oliveira CA, McCammon JA., J. Mol. Recognit. 23(2), 2010
PMID: 19882751
Zinc-binding groups modulate selective inhibition of MMPs.
Agrawal A, Romero-Perez D, Jacobsen JA, Villarreal FJ, Cohen SM., ChemMedChem 3(5), 2008
PMID: 18181119
Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I.
Temperini C, Innocenti A, Guerri A, Scozzafava A, Rusconi S, Supuran CT., Bioorg. Med. Chem. Lett. 17(8), 2007
PMID: 17314045
The design of inhibitors for medicinally relevant metalloproteins.
Jacobsen FE, Lewis JA, Cohen SM., ChemMedChem 2(2), 2007
PMID: 17163561
N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors.
Temperini C, Innocenti A, Scozzafava A, Supuran CT., Bioorg. Med. Chem. Lett. 16(16), 2006
PMID: 16759856

34 References

Data provided by Europe PubMed Central.

Matrilysin-inhibitor complexes: common themes among metalloproteases.
Browner MF, Smith WW, Castelhano AL., Biochemistry 34(20), 1995
PMID: 7756291
Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.
Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M., J. Med. Chem. 42(26), 1999
PMID: 10639284
Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: implications for drug design.
Gavuzzo E, Pochetti G, Mazza F, Gallina C, Gorini B, D'Alessio S, Pieper M, Tschesche H, Tucker PA., J. Med. Chem. 43(18), 2000
PMID: 10978185
The application of x-ray, NMR, and molecular modeling in the design of MMP inhibitors.
Rush TS 3rd, Powers R., Curr Top Med Chem 4(12), 2004
PMID: 15320728

Remko, Struct. Chem. 15(), 2004
QXP: powerful, rapid computer algorithms for structure-based drug design.
McMartin C, Bohacek RS., J. Comput. Aided Mol. Des. 11(4), 1997
PMID: 9334900

AUTHOR UNKNOWN, 0
Metal complexes of 1-substituted 3-hydroxyureas.
Harmon RE, Dabrowiak JC, Brown DJ, Gupta SK, Herbert M, Chitharanjan D., J. Med. Chem. 13(3), 1970
PMID: 5441147

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 16242329
PubMed | Europe PMC

Search this title in

Google Scholar